NCT04662411 - Butyrate/Hexanoate in Metabolic Health | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 13, 2021

Primary Completion Date

July 26, 2021

Study Completion Date

July 26, 2021

Conditions

Metabolic Disease

Interventions

DIETARY_SUPPLEMENT

Placebo

acute intake of 0 mg butyrate and hexanoate

DIETARY_SUPPLEMENT

butyrate and hexanoate amount 1

acute intake of 650 mg butyrate and hexanoate

DIETARY_SUPPLEMENT

butyrate and hexanoate amount 2

acute intake of 1325 mg butyrate and hexanoate

DIETARY_SUPPLEMENT

butyrate and hexanoate amount 3

acute intake of 2000 mg butyrate and hexanoate

Trial Locations (1)

Maastricht University Medical Centre, Maastricht

All Listed Sponsors

lead

Maastricht University Medical Center

OTHER